Neumous

Cheongju, South Korea Founded: 2022 • Age: 4 yrs
Develops innovative non-invasive ultrasound technologies for treating brain diseases without surgery.

About Neumous

Neumous is a Healthcare company based in Cheongju (South Korea) founded in 2022. It develops innovative non-invasive ultrasound technologies for treating brain diseases without surgery. It operates on a B2B model. Its focus areas include Medical Devices, Neurology and Ultrasound Technology.

Company details

Neumous, based in Cheongju, focuses on providing healthcare solutions, developing medical devices, neurology, and ultrasound technology. Develops innovative non-invasive ultrasound technologies for treating brain diseases without surgery. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Cheongju, South Korea
  • Sectors
    Healthcare
  • Website neumous.com
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Neumous

Neumous was founded in 2022.

Neumous is headquartered in Cheongju, South Korea. It is registered at Cheongju, Chungcheongbuk-do, South Korea.

Neumous, based in Cheongju, focuses on providing healthcare solutions, developing medical devices, neurology, and ultrasound technology. Develops innovative non-invasive ultrasound technologies for treating brain diseases without surgery. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available